Pharmacokinetic assessment of Standard Half-Life (SHL) FVIII, Extended Half-Life (EHL) FVIII, and efanesoctocog alfa (BIVV001) in Severe Hemophilia A

Trial Identifier:	PKM17085
Sponsor:	Sanofi
Start Date:	August 2021
Primary Completion Date:	November 2021
Study Completion Date:	November 2021
Condition:	Hemophilia

Available Languages

For questions about your Trial Results Summary, please see Sponsor contact section within your Trial Results Summary.

Language	Description

Stay informed about new Trial Results Summaries with our email notification service

Trial Locations

Country	Location
Bulgaria	Sofia, Bulgaria, 1756

Pharma Intelligence UK Limited is a company registered in England and Wales with company number 13787459 whose registered office is 3 More London Riverside, London SE1 2AQ.